Clinical Trial Update: To Determine the Effects of Deodorant, Antiperspirant and Washing on the Pharmacokinetics of 2% Testosterone MD Lotion [Phase 1]

View source ↗

Summary

Phase 1 study assessing how deodorant, antiperspirant, and washing affect the pharmacokinetics of 2% testosterone MD Lotion in individuals with hypogonadism; th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypogonadism

Drugs mentioned

• 2% Testosterone MD Lotion (testosterone)

Snippet

Sponsor: Acrux DDS Pty Ltd | Conditions: Hypogonadism | Phase 1 | Status: COMPLETED